Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 New Entrants companies in Enzalutamide
by Most Patent Filing In 3 Years in the world in 2018

The Enzalutamide top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filing In 3 Years Enzalutamide New Entrants in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Enzalutamide is used to treat men with a certain type of prostate cancer.
#
Company Name
Region
Tech Topics
Total
1
Patent: 8
2
Medicine,Health care,Pharmacy and Therapeutics,
...[+2]
Patent: 7
3
Lombardia, Italy
Patent: 6
4
Île-de-France, France
Patent: 6
5
Languedoc-Roussillon, France
Health care,Hospitality industry
Patent: 6
6
Patent: 6
7
Patent: 4
8
Jerusalem, Israel
Health care,Technology transfer,Biomedicine,
...[+2]
Patent: 4
9
Patent: 2
10
Nursing,Health care,Association (object-oriented programming),
...[+2]
Patent: 2
11
Patent: 2
12
Working capital,Pathology,Companion diagnostic,
...[+2]
Patent: 2
13
Patent: 1
14
France
Patent: 1
15
Patent: 1
16
Patent: 1
17
Patent: 1
18
Antwerpen, Belgium
Neurogenetics,Nanostructure,Social policy,
...[+2]
Patent: 1
19
Patent: 1
20
Basel-Stadt, Switzerland
Dosage form,Health care,Medicine,
...[+2]
Patent: 1
Page generation time: Dec 13 2025